The significance of plasma collagen degradation products as biomarkers for advanced hypertensive heart disease

The significance of plasma collagen degradation products as biomarkers for advanced hypertensive heart disease

Bibliographic Details
Main Authors:	Kevin Mani, Arya Mani
Format:	Article
Language:	English
Published:	Wiley 2021-05-01
Series:	The Journal of Clinical Hypertension
Online Access:	https://doi.org/10.1111/jch.14205

Similar Items

Predictive Value of Collagen Biomarkers in Advanced Chronic Kidney Disease Patients
by: Carina Ureche, et al.
Published: (2023-02-01)

Morphological features of collagen degradation in advanced hepatic schistosomiasis of man
by: Zilton A. Andrade
Published: (1992-01-01)

Hypertensive Heart Disease: A Narrative Review Series—Part 3: Vasculature, Biomarkers and the Matrix of Hypertensive Heart Disease
by: Valeriya Nemtsova, et al.
Published: (2024-01-01)

Biomarkers in Painful Symptomatic Knee OA Demonstrate That MRI Assessed Joint Damage and Type II Collagen Degradation Products Are Linked to Disease Progression
by: Nidhi Sofat, et al.
Published: (2019-10-01)

Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
by: Neha Bhat, et al.
Published: (2023-05-01)

Plasma and Peritoneal Fluid Fibronectin and Collagen IV Levels as Potential Biomarkers of Endometriosis
by: Damian Warzecha, et al.
Published: (2022-12-01)

Contribution to the study of collagen degradation
by: Andrea Cavalcanti, et al.
Published: (2002-01-01)

From mouse to human
by: Arya Mani
Published: (2023-12-01)

Current Understanding of Circulating Biomarkers in Pulmonary Hypertension Due to Left Heart Disease
by: Noah Todd, et al.
Published: (2020-10-01)

Research advance of collagen protein in eye diseases
by: Xing-Xing Chen, et al.
Published: (2015-10-01)

06.03 COLLAGEN ACCUMULATION IS A SIGNIFICANT CONTRIBUTOR TO PULMONARY HYPERTENSION-INDUCED LARGE ARTERY STIFFENING
by: C.Y. Ooi, et al.
Published: (2008-09-01)

Plasma haptoglobin as a potential biomarker for coronary artery disease in young hypertensive adults
by: Norbaiyah, Mohamed Bakrim, et al.
Published: (2024)

Collagen Biomarkers for Arthritis Applications
by: James D. Birmingham, et al.
Published: (2006-01-01)

Collagen Biomarkers for Arthritis Applications
by: James D. Birmingham, et al.
Published: (2006-01-01)

«MEMORIES OF FUTURE»: CHANGE IN VERAPAMIL SIGNIFICANCE IN THE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION
by: S. R. Gilyarevskiy
Published: (2015-09-01)

«MEMORIES OF FUTURE»: CHANGE IN VERAPAMIL SIGNIFICANCE IN THE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION
by: S. R. Gilyarevskiy
Published: (2015-09-01)

The role of unfolded states in collagen degradation
by: Salsas Escat, Ramon
Published: (2010)

Clinical significance of markers of collagen metabolism in rheumatic mitral valve disease.
by: Tanima Banerjee, et al.
Published: (2014-01-01)

Collagen VI as a driver and disease biomarker in human fibrosis
by: Williams, L, et al.
Published: (2021)

Cystic fibrosis disease severity correlates with plasma levels of desmosine and isodesmosine, biomarkers of elastin degradation
by: Shuren Ma, et al.
Published: (2019-06-01)

Plasma nitric oxide in dogs with pulmonary hypertension secondary or not to left-sided heart disease
by: J.B. Braz, et al.
Published: (2023-04-01)

CHANGES IN ACTIVITY OF DIFFERENT LINKS OF PLASMA HEMOSTASIS IN PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE
by: A. I. Pastushyna
Published: (2016-04-01)

The transition from hypertension to hypertensive heart disease and heart failure: the PREFERS Hypertension study
by: Mattias Ekström, et al.
Published: (2020-04-01)

An Autologous Macrophage‐Based Phenotypic Transformation‐Collagen Degradation System Treating Advanced Liver Fibrosis
by: Bo‐Wen Duan, et al.
Published: (2024-02-01)

Identification of altered plasma proteins by proteomic study in valvular heart diseases and the potential clinical significance.
by: Ge Gao, et al.
Published: (2013-01-01)

Proteome profiling of early gestational plasma reveals novel biomarkers of congenital heart disease
by: Ya‐Nan Yin, et al.
Published: (2023-12-01)

Identification of potential serum biomarkers for congenital heart disease children with pulmonary arterial hypertension by metabonomics
by: Nan Jin, et al.
Published: (2023-03-01)

Hypertensive heart disease in Africa
by: Akinyemi Aje, et al.
Published: (2017-04-01)

Heart disease, hypertension, and nutrition
Published: (1991)

Macrophage-mediated degradation of crosslinked collagen scaffolds.
by: Yahyouche, A, et al.
Published: (2011)

Secretion of collagenases by Saccharomyces cerevisiae for collagen degradation
by: Han Xiao, et al.
Published: (2022-08-01)

The effect of collagen removal on shear bond strength of four single bottle adhesive systems
by: Kasraie Sh, et al.
Published: (2006-07-01)

Prognostic Significance of a Multimarker Strategy of Biomarkers in Acute Heart Failure
by: P SRINIVAS, et al.
Published: (2014-09-01)

Collagen-binding peptidoglycans inhibit MMP mediated collagen degradation and reduce dermal scarring.
by: Kate Stuart, et al.
Published: (2011-01-01)

Increased plasma DR‐70 (fibrinogen‐fibrin degradation products) concentrations as a diagnostic biomarker in dogs with neoplasms
by: Chiao‐Hsu Ke, et al.
Published: (2023-11-01)

Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure
by: Tatjana Cvetkovic, et al.
Published: (2022-12-01)

Advanced glycation end-products reduce collagen molecular sliding to affect collagen fibril damage mechanisms but not stiffness.
by: Gion Fessel, et al.
Published: (2014-01-01)

Assessment of Right Ventricle Function in Children with Pulmonary Arterial Hypertension - Moving Beyond Longitudinal Motion
by: Mani Ram Krishna
Published: (2021-01-01)

Plasma-Derived Extracellular Vesicles as Potential Biomarkers in Heart Transplant Patient with Chronic Chagas Disease
by: Nuria Cortes-Serra, et al.
Published: (2020-08-01)

Potential biomarkers and targets in reversibility of pulmonary arterial hypertension secondary to congenital heart disease: an explorative study
by: Li Huang, et al.
Published: (2018-03-01)